Genmab reduce beneficio operativo a USD 986 millones en los primeros nueve meses de 2026; ingresos suben un 22% a USD 3,24 mil millones
Genmab reduce beneficio operativo a USD 986 millones en los primeros nueve meses de 2026; ingresos s
Related stories
Riley Permian erwartet im vierten Quartal 2026 Investitionen von 76 bis 88 Millionen US-Dollar
Riley Permian erwartet im vierten Quartal 2026 Investitionen von 76 bis 88 Millionen US-Dollar R
L impact | FX | Nov 05, 2026, 04:08 PM UTC
Genmabs driftsresultat falder til 986 mio. USD i de første ni måneder af 2026
Genmabs driftsresultat falder til 986 mio. USD i de første ni måneder af 2026 Genmabs driftsresu
L impact | FX | Nov 05, 2026, 04:03 PM UTC
GENMAB 9M OPERATING PROFIT USD 986 MILLION
L impact | EARNINGS | Nov 05, 2026, 04:03 PM UTC
GENMAB 9M OPERATING EXPENSES USD 2,018 MILLION
L impact | FX | Nov 05, 2026, 04:02 PM UTC
Fed’s Barkin Says Policy Is Somewhere Around Neutral
Richmond Fed President Tom Barkin says policy is somewhere around neutral and says economic activity is another factor to consider.
L impact | CENTRAL_BANK | Nov 05, 2026, 04:01 PM UTC
US session market picture: S&P 500 -3.45%, Nasdaq 100 -5.77%; EUR/USD -0.04%, WTI +2.34%, WBD leads volume
US session market picture. US index futures: S and P futures is down 3.45 percent, Nasdaq futures is down 5.77 percent, Dow futures is down 2.39 percent and Russell futures is down
M impact | EQUITY | Nov 05, 2026, 04:01 PM UTC